Lilly's Omvoh (mirikizumab-mrkz) demonstrated early and sustained improvement in bowel urgency outcomes for patients with ulcerative colitis

New data from Eli Lilly and Company (NYSE: LLY) showed Omvoh-treated patients with moderately to severely active ulcerative ...
BMJ Open

Quality assessment of irritable bowel syndrome-related medical information on major video platforms in China: a cross-sectional study

Objective In China, a large number of health-related short videos are posted on video platforms, including educational videos ...
Times Online

Bowel screening expansion under way

Health Minister and Pakuranga MP Simeon Brown says the starting age for free bowel screening has been lowered from 60 to 58 ...
Healio

‘Clinical features alone’ sufficient to assess need for small bowel obstruction surgery

Please provide your email address to receive an email when new articles are posted on . Clinical features alone were comparable to CT imaging for determining small bowel obstruction surgery needs.

Comparing behavioral approaches for irritable bowel syndrome

Researchers led by Wake Forest University School of Medicine and Atrium Health have judged the certainty of evidence on ...
TipRanks on MSN

Shanghai Pharmaceuticals’ SPH7854 Study: A Potential Game-Changer for Inflammatory Bowel Disease?

Shanghai Pharmaceuticals Holding Co Class H (($SHPMF)) announced an update on their ongoing clinical study. Shanghai Pharmaceuticals Holding Co.
The Conversation

Are ultramarathon runners really at increased risk of bowel cancer?

Exercise is a cornerstone of good health and evidence shows it can even help prevent cancers returning following treatment. But new findings are raising an unexpected question: could very high-volume ...

Eli Lilly and Company: Lilly's Omvoh (mirikizumab-mrkz) demonstrated early and sustained improvement in bowel urgency outcomes for patients with ulcerative colitis

Phase 3b LUCENT-URGE is the first study in inflammatory bowel disease to assess bowel urgency across three measures - severity, frequency and stool deferral time - ...